MESO•globenewswire•
Mesoblast Participation at Piper Sandler Conference
Summary
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced its participation at the Piper Sandler 37th Annual Healthcare Conference in New York on December 2–4, 2025.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 3, 2025 by globenewswire